Patents by Inventor Mats Okvist

Mats Okvist has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Peptides derived from viral proteins for use as immunogens and dosage reactants
    Patent number: 10501499
    Abstract: The present invention relates to novel peptides and methods for treatment, diagnosis and prognosis of virus infections including infections with HCV, HIV, HPV, CMV and Influenza. The invention further relates to methods for identifying and providing peptides useful for the treatment and diagnosis.
    Type: Grant
    Filed: June 6, 2013
    Date of Patent: December 10, 2019
    Assignee: BIONOR IMMUNO AS
    Inventors: Birger Sorensen, Mats Okvist, Arnt Ove Hovden, Maja Sommerfelt Gronvold
  • Method for reducing HIV-1 reservoir size using multivalent immunogen and reservoir purging agent
    Patent number: 10449245
    Abstract: The present invention relates to novel compositions of active agents and methods for the treatment of HIV infection and AIDS. In particular, the present invention relates to novel methods for treatment of HIV infection and prevention of AIDS.
    Type: Grant
    Filed: January 27, 2015
    Date of Patent: October 22, 2019
    Assignee: Bionor Immuno AS
    Inventors: Anker Lundemose, Mats Ökvist, Arnt Ove Hovden, Maja Sommerfelt Grønvold
  • Method of inducing an anti-HIV-1 immune response comprising administering a C5/TM-GP41 peptide dimer
    Patent number: 10335482
    Abstract: The present invention relates to novel combinations of active agents and methods for the treatment of HIV infection and AIDS. In particular, the present invention relates to novel combinations of (1) therapeutic agents which can effect stabilization of a complex between domains in certain HIV proteins with (2) HIV-specific vaccine peptides.
    Type: Grant
    Filed: June 6, 2013
    Date of Patent: July 2, 2019
    Assignee: BIONOR IMMUNO AS
    Inventors: Birger Sorensen, Mats Okvist, Arnt Ove Hovden, Maja Sommerfelt Gronvold, Lars Hoie, Anker Lundemose, Vidar Wendel Hansen
  • Method for the vaccination against HIV
    Patent number: 10143737
    Abstract: The present invention relates to novel compositions of active agents and methods for the treatment of HIV infection and AIDS. In particular, the present invention relates to novel methods to select HIV infected patients with improved responses to HIV-specific vaccine peptides.
    Type: Grant
    Filed: January 27, 2015
    Date of Patent: December 4, 2018
    Assignee: BIONOR PHARMA ASA
    Inventors: Anker Lundemose, Mats Ökvist, Arnt Ove Hovden, Maja Sommerfelt Grønvold
  • DOSAGE REGIMEN FOR HIV VACCINE
    Publication number: 20180140694
    Abstract: The present invention relates to a novel dosage regimen in the treatment of HIV infections and AIDS. In particular, the present invention relates to a specific novel use of formulations of HIV-specific protein therapeutics, such as anti-HIV-1 specific antibodies and/or HIV-specific vaccine peptides, administered in a dosing regimen together with a latent viral reservoir purging agent. The formulations may further be administered with one or more other therapeutic agents, such as in combination with at least one immunomodulatory compound and/or other reservoir purging agents, such as histone deacetylase (HDAC) inhibitors.
    Type: Application
    Filed: May 4, 2016
    Publication date: May 24, 2018
    Applicant: BIONOR IMMUNO AS
    Inventors: Anker Lundemose, Mats Ökvist, Arnt Ove Hovden, Maja Sommerfelt Grønvold
  • METHOD FOR REDUCING AND/OR DELAYING PATHOLOGICAL EFFECTS OF HUMAN IMMUNODEFICIENCY VIRUS I (HIV) OR FOR REDUCING THE RISK OF DEVELOPING ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS)
    Publication number: 20170165321
    Abstract: The present invention relates to novel compositions of active agents and methods for the treatment of HIV infection and AIDS. In particular, the present invention relates to novel methods for treatment of HIV infection and prevention of AIDS.
    Type: Application
    Filed: July 9, 2015
    Publication date: June 15, 2017
    Applicant: Bionor Immuno AS
    Inventors: Anker Lundemose, Mats Ökvist, Arnt Ove Hovden, Maja Sommerfelt Grønvold
  • DOSAGE REGIMEN FOR HIV VACCINE
    Publication number: 20170043009
    Abstract: The present invention relates to novel compositions of active agents and methods for the treatment of HIV infection and AIDS. In particular, the present invention relates to novel methods for treatment of HIV infection and prevention of AIDS.
    Type: Application
    Filed: January 27, 2015
    Publication date: February 16, 2017
    Applicant: Bionor Immuno AS
    Inventors: Anker LUNDEMOSE, Mats ÖKVIST, Arnt Ove HOVDEN, Maja Sommerfelt GRØNVOLD
  • METHOD FOR THE VACCINATION AGAINST HIV
    Publication number: 20170000876
    Abstract: The present invention relates to novel compositions of active agents and methods for the treatment of HIV infection and AIDS. In particular, the present invention relates to novel methods to select HIV infected patients with improved responses to HIV-specific vaccine peptides.
    Type: Application
    Filed: January 27, 2015
    Publication date: January 5, 2017
    Applicant: Bionor Immuno AS
    Inventors: Anker LUNDEMOSE, Mats ÖKVIST, Arnt Ove HOVDEN, Maja Sommerfelt GRØNVOLD
  • VACCINE
    Publication number: 20150174235
    Abstract: The present invention relates to novel combinations of active agents and methods for treatment of retrovirus infections including HIV infections and AIDS. In particular, the present invention relates to novel use of administrations and combinations of a compound to stimulate the humoral immunity and/or peptides that elicit a cell-mediated immune response in a subject; and immunomodulatory compounds and/or a reservoir purging agent, such as a histone deacetylase (HDAC) inhibitor.
    Type: Application
    Filed: June 6, 2013
    Publication date: June 25, 2015
    Inventors: Lars Hoie, Anker Lundemose, Mats Okvist, Arnt Ove Hovden, Maja Sommerfelt Gronvold, Vidar Wendel Hansen, Birger Sorensen
  • PEPTIDES DERIVED FROM VIRAL PROTEINS FOR USE AS IMMUNOGENS AND DOSAGE REACTANTS
    Publication number: 20150152140
    Abstract: The present invention relates to novel peptides and methods for treatment, diagnosis and prognosis of virus infections including infections with HCV, HIV, HPV, CMV and Influenza. The invention further relates to methods for identifying and providing peptides useful for the treatment and diagnosis.
    Type: Application
    Filed: June 6, 2013
    Publication date: June 4, 2015
    Inventors: Birger Sorensen, Mats Okvist, Arnt Ove Hovden, Maja Sommerfelt Gronvold
  • HIV VACCINE
    Publication number: 20150132255
    Abstract: The present invention relates to novel combinations of active agents and methods for the treatment of HIV infection and AIDS. In particular, the present invention relates to novel combinations of (1) therapeutic agents which can effect stabilisation of a complex between domains in certain HIV proteins with (2) HIV-specific vaccine peptides.
    Type: Application
    Filed: June 6, 2013
    Publication date: May 14, 2015
    Applicant: Bionor Immuno AS
    Inventors: Birger Sorensen, Mats Okvist, Arnt Ove Hovden, Maja Sommerfelt Gronvold, Lars Hoie, Anker Lundemose, Vidar Wendel Hansen